Anika Therapeutics (ANIK) Accounts Payables (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Accounts Payables of $6.2 million for Q2 2026, up 30.71% year-over-year from $4.8 million in Q2 2025, and down 1.62% quarter-over-quarter from $6.3 million in Q1 2026.
Anika Therapeutics (ANIK) Accounts Payables (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Accounts Payables for 17 consecutive years, with $6.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accounts Payables rose 30.71% year-over-year to $6.2 million; the TTM figure through Jun 2026 stood at $6.2 million (up 30.71% YoY), while the FY2025 annual figure was $6.0 million, up 7.55% from the prior year.
- Accounts Payables fell to $6.2 million in Q2 2026 per ANIK's latest filing, from $6.3 million in the prior quarter.
- Across five years, Accounts Payables topped out at $10.0 million in Q1 2024 and bottomed at $4.7 million in Q3 2025.
- Historically, Accounts Payables has averaged $7.2 million across 5 years, with a median of $7.1 million in 2022.
- Annual changes were most pronounced in 2025 — Accounts Payables tumbled 52.26% — and 2026, when it surged 30.71%.
- Anika Therapeutics' Accounts Payables stood at $9.1 million in 2022, then sank by 31.74% to $6.2 million in 2023, then declined by 9.32% to $5.6 million in 2024, then grew by 7.55% to $6.0 million in 2025, then gained by 3.23% to $6.2 million in 2026.
- Business Quant data shows ANIK's Accounts Payables at $6.2 million in Q2 2026, $6.3 million in Q1 2026, and $6.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Anika Therapeutics | 285.40 Mn | 246.98 Mn | 21.24 Mn | 6.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.24 Mn |
| Mar 31, 2026 | 6.34 Mn |
| Dec 31, 2025 | 6.04 Mn |
| Sep 30, 2025 | 4.73 Mn |
| Jun 30, 2025 | 4.77 Mn |
| Mar 31, 2025 | 5.28 Mn |
| Dec 31, 2024 | 5.62 Mn |
| Sep 30, 2024 | 6.81 Mn |
| Jun 30, 2024 | 9.99 Mn |
| Mar 31, 2024 | 10.02 Mn |
| Dec 31, 2023 | 6.19 Mn |
| Sep 30, 2023 | 8.25 Mn |
| Jun 30, 2023 | 7.94 Mn |
| Mar 31, 2023 | 8.95 Mn |
| Dec 31, 2022 | 9.07 Mn |
| Sep 30, 2022 | 8.35 Mn |
| Jun 30, 2022 | 8.17 Mn |
| Mar 31, 2022 | 7.44 Mn |
| Dec 31, 2021 | 7.63 Mn |
| Sep 30, 2021 | 7.94 Mn |